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Background: We previously showed that human papillomavirus (HPV) serostatus was not an independent risk
factor for esophageal squamous cell carcinoma(ESCC) in nonsmokers and nondrinkers; however, HPV increased the
risk in smokers.
Methods: Here we investigated possible interactions between HPV16 serostatus and three susceptibility loci
identified in GWASs at apoptosis associated genes with regard to risk of ESCC in a case–control study of 313
patients with ESCC and 314 healthy controls. The loci (CHK2 rs738722, C12orf51 rs2074356, and PLCE1 rs2274223)
were genotyped, and the presence or absence of HPV16 in serum was measured by ELISA. Multivariable logistic
regression was used to evaluate possible interactions of HPV16 serostatus and the three loci on the risk of ESCC.
Results: A significant interaction was found between HPV16 serology and rs2074356 (P = 0.005, odds ratio [OR] 1.40,
95% confidence interval [CI] 1.11–1.77) or rs2274223 (P < 0.001, OR 1.53, 95% CI 1.23–1.91), but not for rs738722.
For rs2074356, risk of ESCC was increased substantially in smokers (P < 0.001, OR 8.25, 95% CI 3.84–17.71) and
drinkers (OR4.04, P = 0.001, 95% CI 1.79–9.10) who carried risk alleles (TT or TC genotype) and were
HPV16-seropositive. Similar results were observed for rs2274223 in smokers (P < 0.001, OR6.06, 95% CI 2.85–12.88)
and drinkers (P < 0.001, OR 5.43, 95% CI 2.51–11.76), but not for rs738722.
Conclusion: Consistent with the previous study, loci at rs2074356 and rs2274223 could increase the risk of ESCC,
furthermore, there were significant interactions between HPV sero-status and the susceptibility loci on the risk of
ESCC. This effect could be modified obviously by smoking and drinking.
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Esophageal cancer is the sixth leading cause of cancer-
related death globally. An estimated 482,300 new esopha-
geal cancer cases were diagnosed and 406,800 died of
esophageal cancer worldwide in 2008. In high-risk areas
such as northern Iran, Central Asian countries, and north
central China, esophageal squamous cell carcinoma (SCC)* Correspondence: yxl@medmail.com.cn
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unless otherwise stated.accounts for 90% of esophageal cancers [1]. Poor nutri-
tional status, low intake of fruits and vegetables, drinking
hot beverages, and smoking all contribute to the etiology
of ESCC [2-4]. In 1982, Syrjanen and colleagues impli-
cated human papillomavirus (HPV) infection in the devel-
opment of squamous cell papillomas of the esophagus,
[5], but the role of HPV infection in esophageal cancer re-
mains controversial.
HPV infection is a risk factor for the development of
several types of tumors, particularly HPV16 and HPV18
infection and cervical cancer [6]. HPV16 was reported tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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esophageal cancer in China [7]. The HPV early protein,
E6 can inhibit the activation of apoptosis through binding
to p53 and targeting it for degradation, and further cause
the malignant transformation [8]. Although HPV infection
combined with smoking and drinking could increase the
risk of ESCC [9], only a fraction of ESCCs are associated
with HPV infection, implying that other genetic factors
can modify the association between HPV infection and
the risk of ESCC.
There were many newly identified susceptibility loci
on the risk of ESCC in the recently published GWAS
studies [10-12]. Based on these three studies, significant
susceptibility loci in apoptosis-related genes, including
loci in 10q23, 22q12 and 12q24, were chosen. PLCE1
(phospholipase C epsilon gene 1) at 10q23 interacts with
the proto-oncogene ras and acts on GTPases involved in
regulating cell growth, differentiation, apoptosis, and
angiogenesis [13,14]. As five susceptibility loci located in
PLCE1 at 10q23 had strong pair-wise linkage disequilib-
rium, we chose the most significant locus rs2274223.
This locus was not only a shared locus for these three
GWAS studies, but also a shared susceptibility locus for
both ESCC and Gastric cancer [10]. CHK2 at 22q12,
participates in the Chk2-p53-PUMA signaling pathway,
is a major regulator of apoptosis induced by DNA dam-
age in response to double-strand breaks in vivo [15]. As
for 22q12, only one susceptibility locus rs738722 located
in CHK2 appeared significantly [10]. C12orf51 transcript
on 12q24 and has been reported to be in high linkage
disequilibrium with SNPs in ALDH2 and ALDH2 was
reported to be associated with cardiomyocyte apoptosis
post myocardial infarction induced by microRNA-34A,
and H₂O₂-induced apoptosis in peripheral blood mono-
nuclear cells [16,17]. As for 12q24, three variants in high
linkage disequilibrium conferred their risks to ESCC in a
gene-life style interaction manner, with more pronounced
risk enhancement seen in tobacco and alcohol users.
Among these three variants located in 12q24, only associ-
ation with rs2074356 remained genome-wide significant
after adjusting for the effects of the other two variants, in-
dicating rs2074356 could be an independent susceptibility
marker [11]. Therefore, rs2074356 was chosen.
To our knowledge, no studies have been performed to
investigate the interactions of the three SNPs CHK2
rs738722, C12orf51 rs2074356, and PLCE1 rs2274223 at
apoptosis associated genes and HPV16 serostatus on the
risk of ESCC. Therefore, in this study, we analyzed inter-
actions among HPV16 seropositivity and these suscepti-
bility loci on ESCC risk. Because drinking and smoking
are risk factors for ESCC in the general population [18],
we also investigated the joint effects of smoking or
drinking, the selected loci, and HPV16 seropositivity on
ESCC risk.Methods
Cases and controls
This study included 313 patients with ESCC and 314
healthy controls, all genetically unrelated Han Chinese.
The 313 patients with ESCC were consecutive cases seen
at Tongji Hospital between 2009 and 2012 who had histo-
pathologically confirmed primary ESCC. Patients who had
primary tumors outside of the esophagus, tumors of un-
known origin, or any histopathologic diagnosis other
than ESCC were excluded. Healthy controls were volun-
teers from Tongji Hospital Physical Center who had re-
ceived a comprehensive health examination and were
found to be cancer-free. All of the cases and controls
come from Hubei Province. In addition, healthy con-
trols were matched to cases on age and sex.
Eligible participants were interviewed by trained staff
using a questionnaire to collect demographic data (age,
sex, address) and related exposure information, including
tobacco and alcohol use. Participants who smoked at least
one cigarette per day for at least 1 year were classified as
“ever-smoking” and others were defined as “nonsmoking”.
Participants who drank alcoholic beverages at least once a
week for more than 1 year were classified as “ever-drink-
ing” and others were classified as “nondrinking”. After the
interview, 2-mL peripheral blood samples were collected
from each participant and stored at −80°C until genotyp-
ing, as described below.
Written informed consent was obtained from each
participant before recruitment. This study was approved
by the ethics committee of the Tongji Medical College.
Genotyping
Genomic DNA was isolated from peripheral blood
samples by using a FUJI whole blood DNA kit (Fujifilm
Corporation, Japan). The three SNPs (rs738722, rs2074356,
and rs2274223) were genotyped by a Taqman real-time
polymerase chain reaction method using a 7900 HT se-
quence detector system (Applied Biosystems, Foster City,
CA, USA). Probes for these three SNPs were ordered from
Applied Biosystems. Allelic discrimination was measured
automatically by Sequence Detection Systems 2.3 software
(Applied Biosystems). For each SNP, more than 98% of the
samples were genotyped successfully. To verify the repro-
ducibility of the Taqman genotyping results, 10% of the
samples were randomly selected and retested. The con-
cordance was 99%.
HPV16 serologic testing
We tested the participants’ serum antibody IgG levels
against the HPV16 L1 capsid protein by using an HPV16
L1-capsid antibody ELISA kit (Cusabio, Wuhan, China) ac-
cording to the manufacturer’s instructions. The cutoff level
for HPV16 L1 seropositivity was determined according to
the manufacturer’s instructions. We randomly chose 5%
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repeat assay.
Statistical analysis
Distributions of demographic characteristics (age, sex),
exposure factors (smoking, drinking, and HPV16 seros-
tatus) and genotypes of the PLCE1 rs2274223, C12orf51
rs2074356 and CHK2 rs738722 variants between cases
and controls were examined with chi-square tests. Po-
tential associations of HPV16 and the three susceptibility
loci genotypes with the risk of ESCC were assessed by
computing odds ratios (ORs) and their 95% confidence
intervals (CIs) by using multivariable logistic regression
analyses. Associations between HPV16 and ESCC risk
were stratified by age, sex, and smoking and drinking
status. Trends in the risk of ESCC associated with the
three susceptibility loci genotypes were estimated and
adjusted for age, sex, smoking and drinking status, and
HPV16 serostatus. Tests for linear trends were per-
formed by treating ordered categorical variables as con-
tinuous variables in the regression analysis. P values for
gene*HPV16 interactions were calculated by conducting
a 1-degree-of-freedom parameter (SNP*HPV16) in an
unconditional logistic regression with age, sex, smoking,
and drinking as covariates [19]. The joint effects of
HPV16 and the three susceptibility loci genotypes were
also estimated and stratified by smoking and drinking.
Statistical analyses were performed with SPSS 16.0 (SPSS
Inc., Chicago, IL, USA). The Hardy–Weinberg equilibriumTable 1 Distribution of demographic variables and risk factor
cancer-free control subjects
Characteristics Cases (n = 313) Contr
Number (%) Numb
Age (years)
<58 152 (48.6) 167
≥58 161 (51.4) 147
Sex
Female 47 (15.0) 51
Male 266 (85.0) 263
Tobacco smoking
Never 92 (29.4) 158
Ever 221 (70.6) 156
Alcohol drinking
Never 115 (36.7) 156
Ever 198 (63.3) 158
HPV status
− 143 (45.7) 178
+ 170 (54.3) 136
P values for cases vs. controls were calculated with two-sided χ2 tests.
*ORs were assessed in logistic regression models.for genotype distribution in controls was tested by a
goodness-of-fit chi-square test. All tests were 2-sided
and P values <0.05 were considered to indicate statisti-
cally significant differences.
Results
Demographic variables and risk factors among study
subjects
We initially enrolled 332 people with esophageal cancer
as cases in this study, later excluding 19 individuals (2
for unknown histopathology, 14 for not having DNA
samples available, and 3 for failure of genotyping), for a
total of 313 ESCC cases and 314 healthy controls.
Among the cases, mean age was 58.6 ± 8.5 years and
85% were male; among the controls, mean age of con-
trols was 57.7 ± 12.1 years, and 84% were male. (P for
age 0.247, P for sex 0.673), indicating adequate fre-
quency matching on age and sex (Table 1). A T-test for
comparison on mean ages between cases and healthy
controls was performed (P = 0.289). A much higher pro-
portion of cases smoked tobacco than controls (70.6%
vs. 40.7%, P < 0.001), and more cases drank alcohol than
controls (63.3% vs. 50.3%, P = 0.001); moreover, more
cases were HPV16 seropositivity (54.3%) than controls
(43.3%, P = 0.006).
Stratified analysis of ESCC risk by HPV16 L1 status
For the group as a whole, risk of ESCC was significantly
higher among people who were HPV16-seropositives in esophageal squamous cell cancer cases and
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1.24–2.39) (Additional file 1: Table S1). Among those
who had ever smoked, the risk of ESCC was also signifi-
cantly higher among HPV16-seropositive than HPV16-
seronegative participants (P = 0.003, OR 1.91, 95% CI
1.25–2.93). Similar results were also observed among
participants older than 58 years (P = 0.006, OR 1.98,
95% CI 1.22–3.21), participants who were male (P = 0.001,
OR 1.85, 95% CI 1.29–2.65), and participants who had
ever drank (P = 0.002, OR 2.03, 95% CI 1.30–3.17). Among
participants who did not smoke or drink, those who
were HPV16-seropositive did not have significantly higher
risk of ESCC than those who were HPV16-seronegative
(P = 0.355, OR 1.35, 95% CI 0.72–2.52).
Among nondrinking and HPV16-seropositive subjects,
those who had ever smoked were at significantly higher
risk of ESCC than were non-smokers (P = 0.034, OR 2.26,
95% CI 1.06–4.79) (Additional file 1: Table S2). However,
among non-smoking and HPV16-seropositive subjects,
those who drank were not at significantly higher risk.
Risk of ESCC was substantially higher among partici-
pants who smoked, drank, and were HPV-seropositive
(P < 0.001, OR 5.03, 95% CI 2.66–9.56) compared with
those who did not smoke, did not drink, and were HPV-
seropositive.Table 2 Association of susceptibility loci identified in previou
Susceptibility Loci Cases (n = 313) Contr
No. % No.
rs738722α
CC (Ref.) 169 54.0 187
CT 122 39.0 109
TT 22 7.0 18
Trend test
TT + CT 144 46.0 127
rs2074356β
CC (Ref.) 196 62.6 227
TT 2 0.6 5
TC 115 36.7 82
Trend test
TT + TC 117 37.3 87
rs2274223γ
AA (Ref.) 172 55.0 209
AG 122 39.0 96
GG 19 6.1 9
Trend test
GG + AG 141 45.1 105
*Genotype distribution of rs738722, rs2074356 and rs2274223 was assessed by Chi-
†ORs were adjusted for age, sex, smoking, drinking and HPV16 status.
αThe observed genotype frequencies of rs738722 among controls were in agreeme
βThe observed genotype frequencies of rs2074356 among controls were in agreem
γThe observed genotype frequencies of rs2274223 among controls were in agreemGenotype distribution of susceptibility loci and
association with ESCC risk
Genotype frequencies of the three selected SNPs in cases
and controls are summarized in Table 2. The observed
genotype frequencies among controls were in agreement
with the Hardy-Weinberg equilibrium (P = 0.689 for
rs738722, P = 0.433 for rs2074356, and P = 0.609 for
rs2274223). For rs738722, no significant difference was
found in the distribution of three genotypes between
cases and controls (P = 0.361). The TT and CT genotypes
were more frequent among cases than controls (TT
7.0% vs. 5.7%; CT 39.0% vs. 34.7%), but ESCC risk was
not increased among those with the TT genotype (OR
1.34, 95% CI 0.68–2.66) or those with the CT genotype
(OR 1.22, 95% CI 0.87–1.73). For rs2074356, compared
with the GG genotype, significantly increased risk of
ESCC was associated with the AG genotype (OR 1.61,
95% CI 1.12–2.30) and the combined AA/AG genotypes
(OR 1.52, 95% CI 1.07–2.16). For rs2274223, compared
with the AA genotype, significantly increased risk of
ESCC was associated with the GG genotype (OR 2.86,
95% CI 1.22–6.71), the AG genotype (OR 1.70, 95% CI
1.20–2.41) and the combined GG/AG genotypes (OR
1.75, 95% CI 1.25–2.46). For rs2074356 and rs2274223,
the risk of ESCC may have increased with increasings GWAS with ESCC risk in cases and controls
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and Ptrend = 0.001 for rs2274223) (Table 2).Interactions of C12orf51 rs2074356 and PLCE1 rs2274223
on the risk of ESCC
As indicated in Table 3, patients with rs2074356 CT/TT
genotypes and rs2274223 GG/AG genotypes simultan-
eously had increased risk of ESCC, compared to patients
with rs2074356 CC and rs2274223 AA genotypes (OR
3.31, 95% CI 1.87–5.83). There was an interaction be-
tween rs2074356 and rs2274223 on the risk of ESCC
(OR 1.26, 95% CI 1.09–1.45).Interactions of HPV16 seropositivity and SNPs at
susceptibility loci on the risk of ESCC
As shown in Table 4, compared to HPV16-seronegative
subjects with the rs738722 CC genotype, the risk of
ESCC increased among HPV16-seropositive participants
with the CC genotype (P = 0.002, OR 2.00, 95% CI 1.29–
3.10) and among HPV16-seropositive subjects with TT
or CT genotype (P = 0.003, OR 2.09, 95% CI 1.29–3.38).
However, the interaction between rs738722 genotypes
and HPV16 serology for ESCC risk was not significant
(P = 0.068). Compared to HPV16-seronegative partici-
pants with the rs2074356 GG genotype, ESCC risk in-
creased among HPV16-seropositive subjects with the
GG genotype (P = 0.005, OR 1.78, 95% CI 1.19–2.66)
and among HPV16-seropositive participants with the
AA or AG genotype (P < 0.001, OR 2.66, 95% CI 1.59–
4.46). Here the interaction between rs2074356 genotypes
and HPV16 serology for ESCC risk was significant (P =
0.005, OR 1.40, 95% CI 1.11–1.77). Compared with
HPV16-seronegative participants with the rs2274223 AA
genotype, the risk of ESCC was elevated among HPV16-
seropositive subjects with the AA genotype (P = 0.042,
OR 1.55, 95% CI 1.02–2.37) and HPV16-seropositive
participants with the GG or AG genotype (P < 0.001, OR
3.17, 95% CI 1.94–5.17). The interaction between
rs2274223 genotypes and HPV16 serology for ESCC risk
was also significant (P < 0.001, OR 1.53, 95% CI, 1.23–
1.91).Table 3 Combined effect of rs2074356 and rs2274223 on the
Rs2074356 Rs2274223 Cases (n = 313)
No. %
CC AA 109 34.8
CC GG/AG 87 27.8
CT/TT AA 63 20.1
CT/TT GG/AG 54 17.3
Rs2074356*rs2274223
*ORs were adjusted for age, sex, smoking and drinking in logistic regression modelStratified analysis of the joint effect of HPV16
seropositivity and SNPs at susceptibility loci on ESCC risk
by smoking or drinking status
As shown above, HPV16 seropositivity synergized with
different rs2074356 or rs2274223 genotypes to increase
the risk of ESCC, but this synergy was not observed for
rs738722. In the general population, smoking and drink-
ing are known risk factors for ESCC [18,20], so we
further stratified the joint effect of HPV16 serology and
the three selected SNPs by smoking or drinking. For
rs2074356, the OR in HPV16-seropositive smokers car-
rying risk alleles (TT or TC genotype) was more than
six times higher than that in HPV16-seronegative smokers
carrying the non-risk alleles (CC genotype), and was
approximately seven times higher than for HPV16-
seropositive nonsmokers carrying risk alleles (TT or TC
genotype) (Figure 1A). Similar results were observed for
the analysis of the joint effects of drinking, rs2074356,
and HPV16 serology (Figure 1B). The effect sizes of
rs2074356 and HPV16 serology in nonsmokers or
nondrinkers were not large (Figures 1A and B). For
rs2274223, the OR in HPV16-seropositive smokers car-
rying risk alleles (GG or AG genotype) was nearly four
times higher than for HPV16-seronegative smokers car-
rying non-risk alleles (AA genotype), and was approxi-
mately three times higher than for HPV16-seropositive
nonsmokers carrying risk alleles (GG or AG genotype)
(Figure 1C). Similar results were seen for the analysis of
the joint effects of drinking, rs2274223, and HPV16 ser-
ology (Figure 1D). For rs738722, risk of ESCC was not in-
creased among HPV16-seropositive smokers or drinkers
with GG/AG alleles compared with HPV16-seropositive
nonsmokers or nondrinkers with GG/AG alleles (data not
shown).Discussion
We found that genotypes at rs2274223 and rs2074356
contributed to the risk of ESCC independently of HPV16
seropositivity, as had been found in previous genome-
wide association studies; however, we found that rs738722
did not contribute to the risk of ESCC. Although HPV16risk of ESCC
Controls (n = 314) Adjusted
P value
Adjusted
OR (95% CI)*No %
146 46.5 1
81 25.8 0.024 1.60 (1.06-2.42)
63 20.1 0.211 1.33 (0.85-2.08)
24 7.6 <0.001 3.31 (1.87-5.83)
0.002 1.26 (1.09-1.45)
s.
Table 4 Joint effects and interactions of HPV16 L1 seropositivity and genotypes at susceptibility loci on the risk of
esophageal squamous cell carcinoma in cases and controls
HPV16
status
Susceptibility Loci Cases (n = 313) Controls (n = 314) Adjusted
P values
Adjusted
OR (95% CI)*No. % No. %
Rrs738722
Negative CC (Ref.) 70 22.4 106 33.8 1.00
Negative TT + CT 73 23.3 72 22.9 0.112 1.45 (0.92-2.30)
Positive CC 99 31.6 81 25.8 0.002 2.00 (1.29-3.10)
Positive TT + CT 71 22.7 55 17.5 0.003 2.09 (1.29-3.38)
G*HPV16 0.068 1.223 (0.99-1.52)
rsrs2074356
Negative CC (Ref.) 87 27.8 128 40.8 1.00
Negative TT + TC 56 17.9 50 15.9 0.054 1.61 (0.99-2.62)
Positive CC 109 33.9 99 31.5 0.005 1.78 (1.19-2.66)
Positive TT + TC 61 19.5 37 11.8 <0.001 2.66 (1.59-4.46)
G*HPV16 0.005 1.40 (1.11-1.77)
rsrs2274223
Negative AA (Ref.) 82 26.2 118 37.6 1.00
Negative GG + AG 61 19.5 60 19.1 0.055 1.59 (0.99-2.55)
Positive AA 90 28.8 91 29.0 0.042 1.55 (1.02-2.37)
Positive GG + AG 80 25.6 45 14.3 <0.001 3.17 (1.94-5.17)
GG*HPV16 <0.001 1.53 (1.23-1.91)
*ORs were adjusted for age, sex, smoking and drinking in logistic regression models.
P values for gene*HPV16 interaction were calculated by conducting a 1-degree-of-freedom parameter (SNP*HPV16) as implemented in unconditional logistic
regression with age, sex, smoking and drinking as covariates (22).
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nonsmokers and nondrinkers, the interaction of HPV16
serostatus and rs2074356 or rs2274223 significantly in-
creased the risk of ESCC in these subjects. In addition,
smoking and drinking synergized with the joint effect of
HPV16 serostatus and rs2074356 or rs2274223 to sub-
stantially increase ESCC risk. To our knowledge, our
study is the first to analyze interactions of HPV16 sero-
positivity and genotypes at apoptosis associated genes
for the risk of ESCC.
Our multivariable logistic regression models showed
no association between rs738722 and the risk of ESCC
after adjusting for age, sex, smoking, drinking, and
HPV16 status. This is consistent with findings from a
previous genome-wide association study that the appar-
ent association between rs738722 and ESCC risk was
not statistically significant in the second phase (Ptrend =
0.14, OR 1.20, 95% CI 0.94–1.53) [10]. Another study
also reported that variant alleles of CHEK2 rs738722
were not associated with risk of ESCC [21]. Further
study is needed to investigate the association between
rs738722 and ESCC risk.
Findings from studies of HPV16 and risk of ESCC
have been inconsistent [22-24]. Testing methods,demographic and ethnic factors, and exposure to other
ESCC risks may contribute to the inconsistencies among
the results. Similar to the methods used in our study,
serological markers of HPV have been used in other
studies to investigate potential associations between
HPV serostatus and ESCC risk [25-28]. The effect of
HPV16 seropositivity on ESCC risk in our current study
is consistent with our previous study [29]. The current
study included a larger number of cases (313 vs. 225)
and a better method of identifying HPV seropositivity
via identification of antibodies against HPV16 L1 rather
than merely high-risk HPV.
Similar studies have been done to investigate joint
effects of genetic polymorphisms and HPV infec-
tion on risk of ESCC. HLA-DRB1*1501 and HLA-
DQB1*0301 was reported to influence HPV-encoded
epitopes and affect the risk of ESCC among Kazakhs
in XinJiang, China [30]. Our another previous study
demonstrated that HPV16 seropositivity synergized
with p53 Arg/Arg or Arg/Pro and increased ESCC
risk, especially in smokers or drinkers [31]. However,
until now no studies have investigated the joint effect
of HPV16 seropositivity, susceptibility loci, and the
effects of smoking and drinking on risk of ESCC.
Figure 1 Odds ratios for esophageal squamous cell carcinoma
(ESCC) in smokers/drinkers and nonsmokers/nondrinkers with
different rs2074356/rs2274223 genotypes and HPV16 serology.
A, Odds ratios for ESCC in smokers and nonsmokers with different
rs2074356 and HPV16 serology. Non-smoker, CC and HPV16- was
reference for A. B, Odds ratios for ESCC in drinkers and nondrinkers
with different rs2074356 and HPV16 serology. Non-drinker, CC and
HPV16- was reference for B. C, Odds ratios for ESCC in smokers and
nonsmokers with different rs2274223 and HPV16 serology. Non-smoker,
AA and HPV16- was reference for C. D, Odds ratios for ESCC in
drinkers and nondrinkers with different rs2274223and HPV16
serology. Non-drinker, AA and HPV16- was reference for Figure D.
The vertical bars represent the 95% confidence intervals.
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After HPV infection, the E6 protein can bind to p53
through E6AP and prevent p53 from inducing apoptosis
through targeting it for degradation via the ubiquitin–
proteasome pathway [32]. Risk alleles at apoptosis genes
may contribute to the inhibition of apoptosis and this
could explain our results why HPV could synergize with
susceptibility loci identified in GWASs at apoptosis asso-
ciated genes to increase the risk of ESCC.
Our study did have some limitations, including the
fact that all of the individuals enrolled in our study were
ethnic Han Chinese and all of them were from Hubei
Province. Our study is retrospective and hospital based.
All of the controls were from Hubei Province, China, re-
ceived a comprehensive examination of health and found
to be cancer free. The majority of the controls come
from city and there are more rural residents in cases,
therefore, there may be differences of the lifestyle, social
economic status (SES), education level, food habits and
so on between controls and cases. However, in this
study, information of these factors is not accessible. Lack
of the information of these factors may resulted in selec-
tion bias and limited representativeness of samples. In
our further research, lifestyle, SES, education level, and
food habits will be evaluated for the new participants to
reduce the selection bias and limited representativeness
of the samples. Our study still needs to be further vali-
dated in other parts of China or other ethnics.Conclusions
In summary, we found that SNPs at two susceptibility
loci identified in previous genome-wide association stud-
ies (rs2274223 and rs2074356) increased the risk of
ESCC independent of HPV16 seropositivity, but a third
SNP (rs738722) did not. HPV16 serostatus was not an
independent risk factor in nonsmokers and nondrinkers.
However, interactions between HPV16 seropositivity and
risk alleles of rs2074356 or rs2274223 increased the risk
of ESCC substantially, especially in smokers or drinkers.
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Additional file 1: Table S1. Associations between age, sex, smoking,
drinking, and risk of ESCC stratified by HPV16 infection. Table S2.
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